Eps Summary of Oncopeptides AB (publ)

Oncopeptides AB (publ)'s latest annual eps in 2023 was -2.76 SEK , up 52.31% from previous year.
Oncopeptides AB (publ)'s latest quarterly eps in 2024 Q2 was -0.35 SEK , up 9.43% from previous quarter.
Oncopeptides AB (publ) reported an annual eps of -4.11 SEK in 2022, up 78.37% from previous year.
Oncopeptides AB (publ) reported an annual eps of -19.00 SEK in 2021, up 25.69% from previous year.
Oncopeptides AB (publ) reported a quarterly eps of -0.53 SEK for 2024 Q1, up 41.11% from previous quarter.
Oncopeptides AB (publ) reported a quarterly eps of -0.62 SEK for 2023 Q2, up 21.52% from previous quarter.

Annual Eps Chart of Oncopeptides AB (publ) (2023 - 2014)

Historical Annual Eps of Oncopeptides AB (publ) (2023 - 2014)

Year	Eps	Eps Growth
2023	-2.76 SEK	52.31%
2022	-4.11 SEK	78.37%
2021	-19.00 SEK	25.69%
2020	-25.57 SEK	-78.44%
2019	-14.33 SEK	-46.67%
2018	-9.77 SEK	-52.9%
2017	-6.39 SEK	-116.61%
2016	-2.95 SEK	-115.33%
2015	-1.37 SEK	-61.18%
2014	-0.85 SEK	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.35 SEK	9.43%
2024 Q1	-0.53 SEK	41.11%
2023 Q2	-0.62 SEK	21.52%
2023 Q3	-0.45 SEK	27.42%
2023 Q1	-0.79 SEK	21.78%
2023 Q4	-0.90 SEK	-100.0%
2023 FY	- SEK	52.31%
2022 Q1	-1.31 SEK	72.3%
2022 FY	- SEK	78.37%
2022 Q2	-0.79 SEK	39.69%
2022 Q4	-1.01 SEK	-1.0%
2022 Q3	-1.00 SEK	-26.58%
2021 Q4	-4.73 SEK	54.21%
2021 FY	- SEK	25.69%
2021 Q1	-3.45 SEK	54.55%
2021 Q2	-0.32 SEK	90.72%
2021 Q3	-10.33 SEK	-3128.13%
2020 Q4	-7.59 SEK	-32.92%
2020 Q3	-5.71 SEK	15.91%
2020 Q1	-5.37 SEK	-21.49%
2020 FY	- SEK	-78.44%
2020 Q2	-6.79 SEK	-26.44%
2019 Q3	-3.53 SEK	-0.28%
2019 FY	- SEK	-46.67%
2019 Q4	-4.42 SEK	-25.21%
2019 Q2	-3.52 SEK	-36.96%
2019 Q1	-2.57 SEK	-1.58%
2018 Q1	-1.56 SEK	7.14%
2018 FY	- SEK	-52.9%
2018 Q4	-2.53 SEK	-8.12%
2018 Q3	-2.34 SEK	28.22%
2018 Q2	-3.26 SEK	-108.97%
2017 Q4	-1.68 SEK	-29.23%
2017 Q1	-1.89 SEK	-44.27%
2017 Q2	-1.69 SEK	10.58%
2017 Q3	-1.30 SEK	23.08%
2017 FY	- SEK	-116.61%
2016 Q1	-0.92 SEK	0.0%
2016 Q2	-0.60 SEK	34.78%
2016 Q4	-1.31 SEK	-104.69%
2016 FY	- SEK	-115.33%
2016 Q3	-0.64 SEK	-6.67%
2015 FY	- SEK	-61.18%
2014 FY	- SEK	0.0%

Peer Eps Comparison of Oncopeptides AB (publ)

Name	Eps	Eps Difference
Capstone Therapeutics Corp.	-36.39 USD	92.415%
Skye Bioscience, Inc.	-5.37 USD	48.603%
Santhera Pharmaceuticals Holding AG	5.95 USD	146.387%
Nascent Biotech, Inc.	-0.01 USD	-20497.015%
Qrons Inc.	-0.06 USD	-4634.134%
Adynxx, Inc.	- USD	Infinity%
BioStem Technologies, Inc.	-0.62 USD	-345.161%
CSL Limited	2.73 USD	201.099%
Evofem Biosciences, Inc.	10.35 USD	126.667%
Arch Therapeutics, Inc.	-2.27 USD	-21.586%
Regen BioPharma, Inc.	0.26 USD	1161.538%
Northwest Biotherapeutics, Inc.	-0.06 USD	-4700.0%
ProtoKinetix, Incorporated	-0.01 USD	-27500.0%
Rebus Holdings, Inc.	-0.03 USD	-8498.131%
Burzynski Research Institute, Inc.	-0.01 USD	-26958.824%
Neon Bloom, Inc.	-0.00 USD	-183900.0%
Acro Biomedical Co., Ltd.	-0.26 USD	-961.538%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	94.565%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-5259.223%
SQZ Biotechnologies Company	-2.76 USD	-0.0%
Intellipharmaceutics International Inc.	-0.09 USD	-3057.895%
Propanc Biopharma, Inc.	-0.02 USD	-11545.57%
Mesoblast Limited	-0.09 USD	-2997.643%
Marizyme, Inc.	-1.44 USD	-91.667%
Genus plc	0.12 USD	2400.0%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	-18.455%
Pharming Group N.V.	-0.02 USD	-17042.857%
Therapeutic Solutions International, Inc.	-0.00 USD	-394185.714%
CNBX Pharmaceuticals Inc.	-0.42 USD	-557.143%
Nymox Pharmaceutical Corporation	-0.10 USD	-2760.104%
ContraFect Corporation	-124.97 USD	97.791%
PsyBio Therapeutics Corp.	-0.04 USD	-6471.429%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-22900.0%
IMV Inc.	-4.37 USD	36.842%
AXIM Biotechnologies, Inc.	-0.04 USD	-7696.61%
MultiCell Technologies, Inc.	-0.00 USD	-2759900.0%
ONE Bio Corp.	1.43 USD	293.007%
Accustem Sciences Inc.	-0.34 USD	-711.765%
RVL Pharmaceuticals plc	-0.58 USD	-375.862%
Arno Therapeutics, Inc.	- USD	Infinity%
EV Biologics, Inc.	-0.12 USD	-2200.0%
Q BioMed Inc.	-0.08 USD	-3433.931%
Emmaus Life Sciences, Inc.	-0.07 USD	-3826.031%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-736.364%
Biomind Labs Inc.	-0.02 USD	-16937.037%
American Oriental Bioengineering, Inc.	-781.24 USD	99.647%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-37197.297%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	-13769.347%
GlobeStar Therapeutics Corporation	-0.00 USD	-114900.0%
THC Farmaceuticals, Inc.	-0.00 USD	-344900.0%
Curative Biotechnology, Inc.	-0.01 USD	-31263.636%
GB Sciences, Inc.	-0.00 USD	-67217.073%
Alpha Cognition Inc.	-0.15 USD	-1740.0%
HST Global, Inc.	-0.03 USD	-9792.473%
Wesana Health Holdings Inc.	-0.05 USD	-5408.982%
Halberd Corporation	-0.00 USD	-2759900.0%
Enzolytics Inc.	-0.00 USD	-394185.714%
Agentix Corp.	-0.04 USD	-7785.714%
Resverlogix Corp.	-0.01 USD	-19336.62%
Nuo Therapeutics, Inc.	-0.08 USD	-3560.477%
MetaStat, Inc.	- USD	Infinity%
argenx SE	-5.16 USD	46.512%
Enzon Pharmaceuticals, Inc.	0.00 USD	212407.692%
Endonovo Therapeutics, Inc.	0.03 USD	11096.016%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-7631.092%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	-13700.0%
AVAX Technologies, Inc.	-0.05 USD	-5020.594%
Zenith Capital Corp.	-0.07 USD	-3848.498%
Genscript Biotech Corporation	-0.05 USD	-5979.295%
Ember Therapeutics, Inc.	-0.01 USD	-43709.524%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	26.79%
WPD Pharmaceuticals Inc.	-0.00 USD	-551900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-2923.001%
Kadimastem Ltd	-0.78 USD	-253.846%
Helix BioMedix, Inc.	-4.70 USD	41.277%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-23093.277%
LadRx Corporation	0.68 USD	505.882%
Cell Source, Inc.	-0.17 USD	-1523.529%
Regen BioPharma, Inc.	0.29 USD	1051.724%
NovAccess Global Inc.	-0.23 USD	-1100.0%
Affymax, Inc.	-0.39 USD	-607.692%
Itoco Inc.	-0.01 USD	-36215.789%
Rasna Therapeutics, Inc.	-0.01 USD	-27500.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-110300.0%
Mobile Lads Corp.	-0.01 USD	-49185.714%
CytoDyn Inc.	-0.05 USD	-5117.391%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-551900.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-12332.432%
Alseres Pharmaceuticals, Inc.	-153.67 USD	98.204%
SYBLEU INC	-0.02 USD	-15671.429%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-19336.62%
International Stem Cell Corporation	-0.02 USD	-16729.268%
Bioxytran, Inc.	-0.03 USD	-8552.038%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-2759900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	65.457%
Adhera Therapeutics, Inc.	-1.18 USD	-133.898%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-8017.647%
Innovation Pharmaceuticals Inc.	-0.01 USD	-43709.524%
Neutra Corp.	-0.00 USD	-2759900.0%
Windtree Therapeutics, Inc.	-94.23 USD	97.071%
PureTech Health plc	-2.38 USD	-15.966%
Coeptis Therapeutics, Inc.	-0.83 USD	-232.53%
IXICO plc	-0.02 USD	-11211.475%
IntelGenx Technologies Corp.	-0.06 USD	-4759.155%
Gelesis Holdings, Inc.	-1.35 USD	-104.444%
CSL Limited	5.47 USD	150.457%
Cellectis S.A.	-1.77 USD	-55.932%

Global Stocks Search

Oncopeptides AB (publ) (ONPPF)

Eps Summary of Oncopeptides AB (publ)

Annual Eps Chart of Oncopeptides AB (publ) (2023 - 2014)

Historical Annual Eps of Oncopeptides AB (publ) (2023 - 2014)

Peer Eps Comparison of Oncopeptides AB (publ)